Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

An open-label phase 1 clinical trial of the anti-α4β7 monoclonal antibody vedolizumab in HIV-infected individuals.

Sneller MC, Clarridge KE, Seamon C, Shi V, Zorawski MD, Justement JS, Blazkova J, Huiting ED, Proschan MA, Mora JR, Shetzline M, Moir S, Lane HC, Chun TW, Fauci AS.

Sci Transl Med. 2019 Sep 11;11(509). pii: eaax3447. doi: 10.1126/scitranslmed.aax3447. Epub 2019 Sep 5.

PMID:
31488581
2.

Tegaserod for female patients suffering from IBS with mixed bowel habits or constipation: a randomized controlled trial.

Chey WD, Paré P, Viegas A, Ligozio G, Shetzline MA.

Am J Gastroenterol. 2008 May;103(5):1217-25. doi: 10.1111/j.1572-0241.2008.01808.x.

3.

Patients with irritable bowel syndrome or constipation have an increased risk for ischaemic colitis.

Suh DC, Kahler KH, Choi IS, Shin H, Kralstein J, Shetzline M.

Aliment Pharmacol Ther. 2007 Mar 15;25(6):681-92.

4.

Safety, tolerability, and efficacy of tegaserod over 13 months in patients with chronic constipation.

Müller-Lissner S, Kamm MA, Musoglu A, Earnest DL, Dunger-Baldauf C, Shetzline MA.

Am J Gastroenterol. 2006 Nov;101(11):2558-69; quiz 2671.

PMID:
17090282
5.

Neurohumoral control of the exocrine pancreas.

Shetzline MA, Liddle RA.

Curr Opin Gastroenterol. 1999 Sep;15(5):380-4.

PMID:
17023977
6.

Effect of tegaserod on esophageal pain threshold, regurgitation, and symptom relief in patients with functional heartburn and mechanical sensitivity.

Rodriguez-Stanley S, Zubaidi S, Proskin HM, Kralstein JR, Shetzline MA, Miner PB Jr.

Clin Gastroenterol Hepatol. 2006 Apr;4(4):442-50.

PMID:
16616348
7.

Factors motivating dyspepsia patients to enter clinical research.

Rojavin MA, Downs P, Shetzline MA, Chilingerian R, Cohard-Radice M.

Contemp Clin Trials. 2006 Apr;27(2):103-11. Epub 2006 Jan 18.

PMID:
16413229
8.

Ischemic colitis, irritable bowel syndrome, and tegaserod--an alternative viewpoint.

Shetzline MA, Cohard-Radice M, Joelsson B.

Pharmacotherapy. 2005 Nov;25(11):1684-5; discussion 1685. No abstract available.

PMID:
16232032
9.

Capsule endoscopy structured terminology (CEST): proposal of a standardized and structured terminology for reporting capsule endoscopy procedures.

Korman LY, Delvaux M, Gay G, Hagenmuller F, Keuchel M, Friedman S, Weinstein M, Shetzline M, Cave D, de Franchis R.

Endoscopy. 2005 Oct;37(10):951-9. Review. No abstract available.

PMID:
16189767
10.

Direct percutaneous endoscopic jejunal feeding tube placement.

Shetzline MA, Suhocki PV, Agrawal N.

Am J Gastroenterol. 2005 Jul;100(7):1627-8; author reply 1628. No abstract available.

PMID:
15985001
11.

Characterization of the alternating bowel habit subtype in patients with irritable bowel syndrome.

Tillisch K, Labus JS, Naliboff BD, Bolus R, Shetzline M, Mayer EA, Chang L.

Am J Gastroenterol. 2005 Apr;100(4):896-904.

PMID:
15784038
12.

A prospective assessment of bowel habit in irritable bowel syndrome in women: defining an alternator.

Drossman DA, Morris CB, Hu Y, Toner BB, Diamant N, Leserman J, Shetzline M, Dalton C, Bangdiwala SI.

Gastroenterology. 2005 Mar;128(3):580-9.

PMID:
15765393
13.
14.

Enterochromaffin cells and 5-HT signaling in the pathophysiology of disorders of gastrointestinal function.

Crowell MD, Shetzline MA, Moses PL, Mawe GM, Talley NJ.

Curr Opin Investig Drugs. 2004 Jan;5(1):55-60. Review.

PMID:
14983974
15.

The importance of indication in the diagnostic value of push enteroscopy.

Lin S, Branch MS, Shetzline M.

Endoscopy. 2003 Apr;35(4):315-21.

PMID:
12664388
16.

Gastrointestinal bleeding in adult patients with Meckel's diverticulum: the role of technetium 99m pertechnetate scan.

Lin S, Suhocki PV, Ludwig KA, Shetzline MA.

South Med J. 2002 Nov;95(11):1338-41.

PMID:
12540005
17.

Vasoactive intestinal polypeptide type-1 receptor regulation. Desensitization, phosphorylation, and sequestration.

Shetzline MA, Walker JK, Valenzano KJ, Premont RT.

J Biol Chem. 2002 Jul 12;277(28):25519-26. Epub 2002 Apr 26.

18.

Endoscopic therapy of acute diverticular hemorrhage.

Bloomfeld RS, Rockey DC, Shetzline MA.

Am J Gastroenterol. 2001 Aug;96(8):2367-72.

PMID:
11513176
19.

Re: Percutaneous endoscopic gastrostomy.

Shetzline MA.

Am J Gastroenterol. 2001 May;96(5):1666-7. No abstract available.

PMID:
11374739
20.

Direct percutaneous endoscopic jejunostomy with small bowel enteroscopy and fluoroscopy.

Shetzline MA, Suhocki PV, Workman MJ.

Gastrointest Endosc. 2001 May;53(6):633-8.

PMID:
11323594
21.

Provocative angiography in obscure gastrointestinal bleeding.

Shetzline MA, Suhocki P, Dash R, Rockey DC.

South Med J. 2000 Dec;93(12):1205-8.

PMID:
11142458
22.

Mice lacking the dopamine transporter display altered regulation of distal colonic motility.

Walker JK, Gainetdinov RR, Mangel AW, Caron MG, Shetzline MA.

Am J Physiol Gastrointest Liver Physiol. 2000 Aug;279(2):G311-8.

23.

Urgent colonoscopy for the diagnosis and treatment of severe diverticular hemorrhage.

Bloomfeld RS, Shetzline M, Rockey D.

N Engl J Med. 2000 May 25;342(21):1608-9; author reply 1610-1. No abstract available.

PMID:
10841679
24.

Properties of secretin receptor internalization differ from those of the beta(2)-adrenergic receptor.

Walker JK, Premont RT, Barak LS, Caron MG, Shetzline MA.

J Biol Chem. 1999 Oct 29;274(44):31515-23.

25.
26.

Pancreatic polypeptide: identification of target tissues using an in vivo radioreceptor assay.

Shetzline MA, Zipf WB, Nishikawara MT.

Peptides. 1998;19(2):279-89.

PMID:
9493860
27.

Presumed arteriovenous malformation mimicking hemosuccus pancreaticus of Santorini's duct with normal pancreatic anatomy.

Williams DM, Shetzline MA, Guarisco SA, Branch MS.

Gastrointest Endosc. 1996 Sep;44(3):348-50. No abstract available.

PMID:
8885362
28.

Identification of tissue insulin receptors: use of a unique in vivo radioreceptor assay.

Whitcomb DC, O'Dorisio TM, Cataland S, Shetzline MA, Nishikawara MT.

Am J Physiol. 1985 Dec;249(6 Pt 1):E561-7.

PMID:
3909827

Supplemental Content

Loading ...
Support Center